Abstract
The contribution of dysregulation of lipid signaling and metabolism to neurodegenerative diseases including Alzheimer's and Parkinson's is the focus of this special issue. Here, the matter of three reviews and one research article is summarized.
Keywords:
biomarker; lipidomics; mass spectrometry; neurodegenerative diseases; sphingolipid.
MeSH terms
-
Alzheimer Disease / genetics
-
Alzheimer Disease / metabolism*
-
Alzheimer Disease / pathology
-
Amyloid beta-Peptides / genetics
-
Amyloid beta-Peptides / metabolism
-
Biomarkers / metabolism
-
Brain / metabolism*
-
Brain / pathology
-
Cerebrosides / metabolism
-
Gene Expression Regulation
-
Humans
-
Lipid Metabolism*
-
Lipidomics / methods*
-
Mass Spectrometry
-
MicroRNAs / genetics
-
MicroRNAs / metabolism
-
Parkinson Disease / genetics
-
Parkinson Disease / metabolism*
-
Parkinson Disease / pathology
-
Sphingolipids / metabolism
-
Sphingomyelins / metabolism
-
tau Proteins / genetics
-
tau Proteins / metabolism
Substances
-
Amyloid beta-Peptides
-
Biomarkers
-
Cerebrosides
-
MAPT protein, human
-
MicroRNAs
-
Sphingolipids
-
Sphingomyelins
-
tau Proteins